Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$58.49 0.80 (1.39%)
2/9/2010 3:59 PM

Shire plc (ADR) (SHPGY)

CAPS Rating:
***

A pharmaceutical company that focuses on meeting the needs of the specialist physician.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating SHPGY

Add Stock to Watchlist

What the Community Thinks

Total Members

83 Outperforms
19 Underperforms
 

All-Stars

33 Outperforms
12 Underperforms
 

Wall Street

9 Outperforms
3 Underperforms
 

Members bullish on SHPGY are also bullish on:

Members bearish on SHPGY are also bearish on:

Ticker Tags

United Kingdom (43), Blue Chip (106), International Stock (684), Growth (1902), Healthcare (711), Pharmaceuticals (149), Large Cap (413), Defensive (1457)
Suggest a tag

Shire plc (ADR) At A Glance

Current Price: $58.49
Last Trade Time: 2/9/2010 3:59 PM
Open: $58.54
Previous Close: $57.69
Daily Range: $58.15 - $58.87
52-Week Range: $31.66 - $62.24
Volume: 242,473
Market Cap: $10.94B
P/E Ratio: 21.53
Compare Our Special Broker Offers!

Stock Trends

SHPGY VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

Shire plc (ADR) (SHPGY)

Avatar VoodooEconomist (83.41) Submitted: 1/05/09 7:24 AM

Possible buyout by PFE

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Shire plc (ADR) (SHPGY)

Avatar TMFBiologyFool (95.94) Submitted: 1/07/09 6:31 PM

Adderall faces generic competition in April and getting patients to switch to Vyvanse will be difficult.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 17 :   1 2 3 4 Next »

Recs

0

 (SHPGY)

Avatar reachnvj (82.74) Submitted: 1/06/10 2:15 PM : Outperform Start Price: $58.82 SHPGY Score: 5.18

If they get the nod from FDA, this stock will take-off. With GENZ dealing with manufacturing issues, SHPGY can take on some market share with their new drug in the same category.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SHPGY)

Avatar sunsluv72 (64.03) Submitted: 11/14/09 6:20 PM : Outperform Start Price: $58.50 SHPGY Score: 2.85

This stock should out perform in the next few months due the shut down and production stop forced by the FDA on Genezyme and Shire is the only other manufacture that is getting back flow to fill orders.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SHPGY)

Avatar TMFBiologyFool (95.94) Submitted: 6/05/09 7:21 PM : Underperform Start Price: $41.16 SHPGY Score: -26.65

Still looks overpriced. Trying to get patients to switch to Vyvanse will be difficult with generic Adderall available.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SHPGY)

Avatar BigBomber (97.80) Submitted: 4/24/09 10:58 AM : Outperform Start Price: $38.45 SHPGY Score: 26.65

Speciality

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (SHPGY)

Avatar VoodooEconomist (83.41) Submitted: 1/05/09 7:24 AM : Outperform Start Price: $44.79 SHPGY Score: 12.78

Possible buyout by PFE

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 17 :   1 2 3 4 Next »

Wall Street

Results 1 - 12 of 12  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackLeerinkSwan 92.83 07/17/09 Outperform NS $40.75+43.52%+14.54%+28.99
TrackSunTrustRH 87.33 06/10/09 Outperform NS $41.35+41.44%+13.47%+27.97
TrackCreditSuiss 93.62 04/28/08 Underperform NS $53.21+9.92%-20.47%-30.39
TrackLehmanBros 85.06 02/08/08 Underperform NS $54.44+7.45%-16.04%-23.49
TrackBernstein 87.54 01/28/08 Underperform NS $55.76+4.90%-16.15%-21.05
TrackRWBaird 87.00 01/09/08 Outperform NS $67.94-13.91%-19.66%+5.75
TrackEveillard 93.31 09/30/07 Outperform NS $73.05-19.93%-26.38%+6.45 Toggle the visibility of 60-Second Pitch and replies
TrackCitigroup 85.92 04/24/07 Outperform NS $65.59-10.82%-23.15%+12.33
TrackBofASec 94.61 04/05/07 Outperform NS $61.86-5.45%-21.10%+15.66
TrackBearStearns 84.85 11/09/06 Outperform NS $55.40+5.57%-18.14%+23.71
TrackDeutscheSec 89.68 10/31/06 Outperform NS $54.27+7.77%-17.59%+25.37
TrackJimCramer < 20 07/26/06 Outperform 3W $47.23+23.85%-9.67%+33.52

Results 1 - 12 of 12  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD01 171ms